Overexpression of Wnt target genes in adenomas of familial adenomatous polyposis patients

Anticancer Research

Volumn 22, Issue 6 A, 2002, Pages 3409-3414

  D'Orazio, Daniel ^a   Muller, Patrick Y ^b   Heinimann, Karl ^a   Albrecht, Christiane ^c   Bendik, Igor ^b   Herzog, Urs ^d   Tondelli, Peter ^d   Bauerfeind, Peter ^c   Müller, Hansjakob ^a   Dobbie, Zuzana ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c Private Dermatological Clinic   (Switzerland)

^d St Claraspital AG   (Switzerland)

Author keywords

C myc; Cyclin D1; Familial adenomatous polyposis; FAP; Gene expression; Wnt

Indexed keywords

BETA CATENIN; CELL PROTEIN; CONDUCTIN; CYCLIN D1; GENE PRODUCT; MYC PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ADENOMATOUS POLYP; ADOLESCENT; ADULT; APC GENE; ARTICLE; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; GENETIC PREDISPOSITION; HUMAN; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SIGNAL TRANSDUCTION;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; ADOLESCENT; ADULT; BETA CATENIN; CYCLIN D1; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; TRANS-ACTIVATORS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0036870676     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Shih IM, Yu J, He TC, Vogelstein B and Kinzler KW: The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Cancer Res 60: 1671-6, 2000.
2. Smits R, Hofland N, Edelmann W, Geugien M, Jagmohan-Changur S, Albuquerque C, Breukel C, Kucherlapati R, Kielman MF and Fodde R: Somatic APC mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity (In Process Citation). Genes Chromosomes Cancer 29: 229-39, 2000.
3. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D and Birchmeier W: Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280: 596-9, 1998.
4. Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S and Kikuchi A: Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J Biol Chem 273: 10823-6, 1998.
5. Rubinfeld B, Tice DA and Polakis P: Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase 1 epsilon. J Biol Chem 276: 39037-45, 2001.
6. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW: Identification of c-MYC as a target of the APC pathway (see comments). Science 281: 1509-12, 1998.
7. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A: The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-7, 1999.
8. Laken SJ, Papadopoulos N, Petersen GM, Gruber SB, Hamilton SR, Giardiello FM, Brensinger JD, Vogelstein B and Kinzler KW: Analysis of masked mutations in familial adenomatous polyposis. Proc Natl Acad Sci USA 96: 2322-6, 1999.
9. Heinimann K, Thompson A, Locher A, Furlanetto T, Bader E, Wolf A, Meier R, Walter K, Bauerfeind P, Marra G, Muller H, Foernzler D and Dobbie Z: Nontruncating APC germ-line mutations and mismatch repair deficiency play a minor role in APC mutation-negative polyposis. Cancer Res 61: 7616-22, 2001.
10. Dobbie Z, D'Orazio D, Attenhofer M and Muller H: Enhanced sensitivity of a modified protein truncation test for exons 1-14 of the adenomatous polyposis coll gene. Biotechniques 27: 705-8, 1999.
11. Bevington PR and Robinson DK: Data Reduction and Error Analysis for the Physical Sciences; New York, NY, USA, McGraw-Hill, 1992.
12. Lamlum H, Ilyas M, Rowan A, Clark S, Johnson V, Bell J, Frayling I, Efstathiou J, Pack K, Payne S, Roylance R, Gorman P, Sheer D, Neale K, Phillips R, Talbot I, Bodmer W and Tomlinson I: The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med 5: 1071-5, 1999.
13. Smalley MJ and Dale TC: Wnt signalling in mammalian development and cancer. Cancer Metastasis Rev 18: 215-30, 1999.
14. Bazarov AV, Adachi S, Li SF, Mateyak MK, Wei S and Sedivy JM: A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation. Cancer Res 6: 1178-86, 2001.
15. Aberle H, Bauer A, Stappert J, Kispert A and Kemler R: Beta-catenin is a target for the ubiquitin-proteasome pathway. Embo J 16: 3797-3804, 1997.